CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Vita 34 AG is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Vita 34 AG
Deutscher Platz 5a
Phone: +49 3414879240p:+49 3414879240 LEIPZIG, 04103  Germany Ticker: V3VV3V

Business Summary
Vita 34 International AG is a Germany-based company engaged in the medical technology sector. The Company is involved in the long-term storage and processing of stem cells from human umbilical cord blood. The cells are collected at the child’s birth and can be used later in his or her life for the treatment of many diseases, such as anemia, diabetes, degenerative joint diseases, cancer, neurological deficits after brain injuries, cartilage damages and others. They also allow the growing of whole organs, such as the liver. On average, one out seven individuals, whose cells are stored, receives autologous stem cell transplant by the age of 70. The Company acts as a cord blood bank and is also engaged in research activities in the area of regenerative medicine, including curing the consequences of strokes and heart attacks. The Company operates in Germany, Spain and Denmark.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202312/31/2022Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Chairman of the Supervisory Board AlexanderGranderath 12/15/2021 12/15/2021
Chairman of the Management Board, Chief Executive Officer WolfgangKnirsch 62 1/1/2022 6/1/2016
Independent Deputy Chairman of the Supervisory Board FlorianSchuhbauer 48 12/15/2021 7/1/2020
3 additional Officers and Directors records available in full report.

Business Names
Business Name
0NLV
Secuvita, S.L.
V3V
Vita 34 International AG

General Information
Number of Employees: 815 (As of 12/31/2022)
Outstanding Shares: 17,431,762 (As of 12/7/2023)
Stock Exchange: ETR
Fax Number: +49 3414879239
Email Address: ir@vita34.de


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, March 28, 2024